JEFFREY ZIGMAN, MD PhD
5323 HARRY HINES BLVD · Dallas, TX 75390
Medi-Weightloss Dallas/Preston Hollow · 10455 North Central Expressway · Dallas, TX 75231
4.7· 31 Google reviews
Listing updated October 2, 2026
No current plans confirmed — RetaMaps has not yet confirmed this practice's intentions regarding retatrutide. Inclusion on RetaMaps does not mean the provider offers or will offer retatrutide.
Medi-Weightloss Dallas/Preston Hollow is a medical weight-management practice in Dallas, Texas, operating under the Medi-Weightloss brand. Its Google profile lists a 4.7-star average from 31 reviews beginning in 2022, 3 of them in the past year, and reviewers point to the staff (11 reviews) and their results (7) most. The Dallas listing shows weight-loss care, semaglutide and tirzepatide, IV therapy, hormone care and telehealth visits. Its website presents its programs as individualized and physician-led, and it notes body composition measurements and a patient website among its added resources.
| Advertises semaglutide today | Yes |
| Advertises tirzepatide today | Yes |
| Telehealth visits | Yes |
| Cash pay accepted | — |
| Accepts insurance — per practice website | Yes |
| Accepting new patients — per practice website | Yes |
"Not listed" means we didn't find this stated on the practice's public pages — it doesn't mean no. — means unknown. Medication rows describe currently FDA-approved GLP-1 medications the practice advertises today, not retatrutide. Confirm details directly with the practice.
Counts computed by RetaMaps from public Google reviews; most recent review 2026-05-02. Read the reviews themselves on the practice's Google listing.
Rated ★4.7 across 31 Google reviews. Of the 31 reviews we analyzed, 29 (94%) are positive (4–5★) and 2 (6%) are negative (1–2★).
Very few complaints — only 2 negative reviews, with no recurring theme.
Amina D.★★★★★2026-05-02Let me start by saying shoutout to Sonia, Tammy, Emma, and all the providers who always take such great care of me. I’m still waiting on my results, but I truly love your professionalism. You’re always so eager to help, and you show up every day with a smile. If you’re looking to lose weight, this is the place to come—they’re the right people to get you on track. They really take the time to understand you, listen to you, and work with you every step of the way. I’m so happy and grateful to be here, working toward achieving my weight loss goals!
Juanita P.★★★★★2026-04-13Amazingggg people!!!
Eva S.★★★★★2025-12-27This location is amazing. The staff are so friendly, so sweet and very thorough with expectations. I appreciate how the nurse didn't rush me and made sure I understood my treatment options. It gave me confidence.
anthony g.★★★★★2025-08-23The place is very outgoing and friendly. I always feel like I am part of a family here. Always greeted with a warm smile
Amarian B.★★★★★2025-08-21I used the program for about a month and had great results!! The team is very encouraging and welcoming. Sonya always had a smile on her face when she greeted me. Tammy is very gentle with her hands and I never had any problems with my vitals or shots. Kimberly is very knowledgeable and made following the diet plan doable and easy. Unfortunately for good reasons I have to pause my weight-loss journey with Medi because I am now pregnant. After I have my baby , I will be coming back to resume my weight-loss and working with this amazing team!
Analysis by RetaMaps of reviews on this practice's public Google Business listing; review themes are detected automatically and reviews reflect their authors' opinions. See all reviews on Google.
5323 HARRY HINES BLVD · Dallas, TX 75390
12200 PARK CENTRAL DR STE 200 · Dallas, TX 75251
5323 HARRY HINES BLVD · Dallas, TX 75390
2001 INWOOD RD · Dallas, TX 75390
Retatrutide is Eli Lilly's investigational once-weekly triple agonist (GIP, GLP-1 and glucagon receptors). Five Phase 3 trials have reported positive results, and Lilly plans to submit it to the FDA in Q1 2027. It is not FDA-approved, has no brand name or price, and cannot be prescribed outside clinical trials or Lilly's physician-requested expanded access program. Products sold online as "research" or compounded retatrutide are not legitimate retatrutide.
Next milestone: TRIUMPH-5 head-to-head vs tirzepatide results (Expected ~Dec 2026)
Sources: Lilly — What to know about retatrutide · Lilly — TRIUMPH-2/TRIUMPH-3 results · BioPharma Dive — FDA submission plans · STAT — Lilly expanded access (Aug 3, 2026) · FDA — Concerns with unapproved GLP-1 drugs